Gregory Paul Savage

Gregory Paul Savage

Auto-generated profile, based on publicly available information

Gregory Paul Savage

CSIRO Manufacturing, Ian Wark Laboratory, Melbourne, 3168, Victoria, Australia

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
BCBenjamin A. Chalmers
Benjamin A. Chalmers
HXHui Xing
Hui Xing
SHSevan Houston
Sevan Houston
CCCharlotte Clark
Charlotte Clark
SGSussan Ghassabian
Sussan Ghassabian
CWCraig Williams
Craig Williams

17 July 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
ETEdwin G. Tse
Edwin G. Tse
SHSevan D. Houston
Sevan D. Houston
CWCraig Williams
Craig Williams
GSG. Paul Savage
G. Paul Savage
LRLouis M. Rendina
Louis M. Rendina
MTMatthew H. Todd
Matthew H. Todd
The replacement of one chemical motif with another that is broadly similar is a common method in medicinal chemistry to modulate the physical and biological properties of a molecule (i.e. bioisosterism). In recent years, bioisosteres such as cubane and bicyclo[1.1.1]pentane (BCP) have been used as highly effective phenyl mimics. Herein we show the successful incorporation of a range of phenyl bioisosteres during the open source optimization of an antimalarial series. Cubane (19) and closo-carborane (23) analogues exhibited improved in vitro potency against Plasmodium falciparum when compared to the parent phenyl compound, however these changes resulted in a reduction in metabolic stability; unusually, enzyme-mediated oxidation was found to take place on the cubane core. A BCP analogue (22) was found to be equipotent to its parent phenyl compound and showed significantly improved metabolic properties. While these results demonstrate the utility of these atypical bioisosteres when used in a medicinal chemistry program, the search to find a suitable bioisostere may well require the preparation of many candidates, in our case, thirty-two compounds.

6 July 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YCYee-Wai Cheung
Yee-Wai Cheung
PRPascal Röthlisberger
Pascal Röthlisberger
AMAriel E. Mechaly
Ariel E. Mechaly
PWPatrick Weber
Patrick Weber
FLFabienne Levi-Acobas
Fabienne Levi-Acobas
JTJulian Tanner
Julian Tanner
Significance: We report the identification of a cubane-modified aptamer (cubamer) against the malaria biomarker Plasmodium vivax lactate dehydrogenase (PvLDH). The cubamer contains the benzene isostere cubane, which is entirely alien to biology. The crystal structure of the cubamer–protein complex reveals a binding mechanism involving the formation of an unprecedented cubane pocket and an unusual C–H⋅⋅⋅O hydrogen bond. Importantly, the cubamer is capable of distinguishing the PvLDH from the Plasmodium falciparum LDH despite a very high sequence homology, which is impossible for unmodified aptamers. Finally, we have used the cubamer to detect PvLDH in a mimetic clinical situation. This approach blending medicinal chemistry and Darwinian evolution can easily be extended to other nonnatural, exotic functional groups.

13 January 2009 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
TATim E. Adams
Tim E. Adams
MSMariana El Sous
Mariana El Sous
BHBill Hawkins
Bill Hawkins
SHSebastian Hirner
Sebastian Hirner
GHGeorgina Holloway
Georgina Holloway
MRMark A. Rizzacasa
Mark A. Rizzacasa

1 January 1994
Verified
Book Chapter
Closed access
CEChristopher J. Easton
Christopher J. Easton
CHC. Merrîcc M. Hughes
C. Merrîcc M. Hughes
GSG. Paul Savage
G. Paul Savage
GSGregory W. Simpson
Gregory W. Simpson

7 June 2011 in Organic Letters
Verified
Journal Article
Closed access
JFJoshua Fischer
Joshua Fischer
GSG. Paul Savage
G. Paul Savage
MCMark J. Coster
Mark J. Coster